Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 11, Pages 602-613
http://dx.doi.org/10.1100/tsw.2011.30
Review Article

Recognition and Treatment of BCG Failure in Bladder Cancer

Department of Urology, University of Iowa, Iowa City, USA

Received 18 August 2010; Revised 13 December 2010; Accepted 22 December 2010

Academic Editor: Karim Kader

Copyright © 2011 Andrew J. Lightfoot et al.

Citations to this Article [16 citations]

The following is the list of published articles that have cited the current article.

  • Willem Oosterlinck, and Karel Decaestecker, “Current strategies in the treatment of non-muscle-invasive bladder cancer,” Expert Review of Anticancer Therapy, vol. 12, no. 8, pp. 1097–1106, 2012. View at Publisher · View at Google Scholar
  • J.M. Laturnus, D. Jocham, and M. Sommerauer, “Das Harnblasenkarzinomrezidiv nach BCG-Instillationstherapie,” Der Urologe, vol. 51, no. 9, pp. 1209–1219, 2012. View at Publisher · View at Google Scholar
  • Kazuhiro Matsumoto, Eiji Kikuchi, Hiroshi Shirakawa, Nozomi Hayakawa, Nobuyuki Tanaka, Akiharu Ninomiya, Akira Miyajima, So Nakamura, and Mototsugu Oya, “Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer,” BJU International, vol. 110, no. 11b, pp. E508–E513, 2012. View at Publisher · View at Google Scholar
  • Anastasios Anastasiadis, and Theo M. De Reijke, “Best practice in the treatment of nonmuscle invasive bladder cancer,” Therapeutic Advances in Urology, vol. 4, no. 1, pp. 13–32, 2012. View at Publisher · View at Google Scholar
  • Kyle G. Potts, Mary M. Hitt, and Ronald B. Moore, “Oncolytic Viruses in the Treatment of Bladder Cancer,” Advances in Urology, vol. 2012, pp. 1–11, 2012. View at Publisher · View at Google Scholar
  • Andrew J. Lightfoot, Benjamin N. Breyer, Henry M. Rosevear, Bradley A. Erickson, Badrinath R. Konety, and Michael A. O'Donnell, “Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer,” Urologic Oncology: Seminars and Original Investigations, 2013. View at Publisher · View at Google Scholar
  • Xinyang Deng, Qi Liu, Yong Hu, and Yong Deng, “TOPPER: Topology Prediction of Transmembrane Protein Based on Evidential Reasoning,” The Scientific World Journal, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Toni O'Regan, Michael Tatton, Maryanne Lyon, and Jonathan Masters, “The effectiveness of BCG and interferon against non-muscle invasive bladder cancer: a New Zealand perspective,” BJU International, 2015. View at Publisher · View at Google Scholar
  • Ashish M. Kamat, Thomas W. Flaig, H. Barton Grossman, Badrinath Konety, Donald Lamm, Michael A. O'Donnell, Edward Uchio, Jason A. Efstathiou, and John A. Taylor, “Expert consensus document: Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer,” Nature Reviews Urology, 2015. View at Publisher · View at Google Scholar
  • Patrick Vianna Garcia, Fábio Rodrigues Ferreira Seiva, Amanda Pocol Carniato, Wilson de Mello Júnior, Nelson Duran, Alda Maria Macedo, Alexandre Gabarra de Oliveira, Rok Romih, Iseu da Silva Nunes, Odilon da Silva Nunes, and Wagner José Fávaro, “Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier,” BMC Cancer, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Queila Cristina Dias, Iseu da Silva Nunes, Patrick Vianna Garcia, and Wagner José Fávaro, “Potential therapeutic strategies for non - muscle invasive bladder cancer based on association of intravesical immunotherapy with P-MAPA and systemic administration of cisplatin and doxorubicin,” International Braz J Urol, vol. 42, no. 5, pp. 942–954, 2016. View at Publisher · View at Google Scholar
  • Ashish M. Kamat, Joaquim Bellmunt, Matthew D. Galsky, Badrinath R. Konety, Donald L. Lamm, David Langham, Cheryl T. Lee, Matthew I. Milowsky, Michael A. O’Donnell, Peter H. O’Donnell, Daniel P. Petrylak, Padmanee Sharma, Eila C. Skinner, Guru Sonpavde, John A. Taylor, Prasanth Abraham, and Jonathan E. Rosenberg, “Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma,” Journal for ImmunoTherapy of Cancer, vol. 5, no. 1, 2017. View at Publisher · View at Google Scholar
  • Kaitlyn M. Dunphy, Mia C. Garino, Nathan M. Shaw, Filipe LF. Carvalho, and Lambros Stamatakis, “When the Gold Standard Proves to be Fool's Gold – Blue Light Cystoscopy in a Case of High Risk Non-Muscle Invasive Bladder Cancer,” Urology, 2017. View at Publisher · View at Google Scholar
  • Lara Paro Dias, Ângela C. Malheiros Luzo, Bruno B. Volpe, Marcela Durán, Sofia E.M. Galdames, Luiz A.B. Ferreira, Nelson Durán, and Wagner J. Fávaro, “Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer,” Tissue and Cell, vol. 52, pp. 17–27, 2018. View at Publisher · View at Google Scholar
  • N. Talji, and N. Mottet, “Bladder Cancer in Older Adults,” Geriatric Oncology, pp. 1–18, 2018. View at Publisher · View at Google Scholar
  • Julieti Huch Buss, Karine Rech Begnini, Camila Bonemann Bender, Adriana R. Pohlmann, Silvia S. Guterres, Tiago Collares, and Fabiana Kömmling Seixas, “Nano-BCG: A Promising Delivery System for Treatment of Human Bladder Cancer,” Frontiers in Pharmacology, vol. 8, 2018. View at Publisher · View at Google Scholar